The frequency of Th2 type cells increases with time on peritoneal dialysis in patients with diabetic nephropathy

European Cytokine Network

Volumn 10, Issue 2, 1999, Pages 219-226

  Zamauskaite, Aurelia ^a   Yaqoob, Mohammed M ^b   Madrigal, J Alejandro ^a   Cohen, Shara B A ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

Dialysis; IDDM; Th1; Th2

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4;

ARTICLE; AUTOIMMUNE DISEASE; CHRONIC GLOMERULONEPHRITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; HELPER CELL; HEMODIALYSIS; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; PERITONEAL DIALYSIS; T LYMPHOCYTE;

AUTOIMMUNE DISEASES; CD4 LYMPHOCYTE COUNT; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; GLOMERULONEPHRITIS; HUMANS; INTERLEUKIN-10; INTERLEUKIN-4; KIDNEY FAILURE, CHRONIC; PERITONEAL DIALYSIS; RENAL DIALYSIS; TH2 CELLS; TIME FACTORS;

EID: 0032782215     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. 1. Cohen G, Haag-Weber M, Horl W H. 1997. Immune dysfunction in uremia. (Review) Kidney Int. Suppl. 62: 79.
2. 2. Descamps-Latscha B. 1993. The immune system in end-stage renal disease. (Review) Curr. Opin. Nephrol Hypertens. 2: 883.
3. 3. Dangirdas J T, Todd S. 1988. Handbook of Dialysis. In: A Little, Brown Handbook, p. 21-39, 182-193, 353-372. Little, Brown and Company, Boston, Massachusetts.
4. 4. Kessler M, Hoen B. 1993. Bacteremia in patients on chronic hemodialysis. A multicenter prospective survey. Nephron. 64: 95.
5. 5. Bloembergen W E, Port F K. 1996. Epidemiological perspective on infections in chronic dialysis patients. (Review) Adv. Ren. Replace Ther. 3: 201.
6. 6. Hakim R M, Held P J, Stannard D C, Daugirdas J T, Agodoa L. 1996. Effect of the dialysis membrane on mortality of chronic hemodialysis patients. Kidney Int. 50: 566.
7. 7. Fenton SS, Schaubel D, Desmeules M, Morrison H I, Mao Y, Copleston P, Jeffery J R, Kjellstrand C M. 1997. Hemodialysis versus peritoneal dialysis: a comparison of adjusted mortality rates. Am. J. Kidney Dis. 30: 334.
8. 8. Bland L A. 1995. Microbiological and endotoxin assays of hemodialysis fluids. (Review) Adv. Ren. Replace Ther. 2: 70.
9. 9. Vanholder R, Van Biessen W, Ringoir S. 1993. Contributing factors to the inhibition of phagocytosis in hemodialysed patients. Kidney Int. 44: 208.
10. 10. Allen J E, Maizels R M. 1997. Th1-Th2: reliable paradigm or dangerous dogma. Immunology Today 18: 387.
11. 11. Sendar D, Rachid A. 1974. In vitro cellular immunity and in vivo delayed hypersensitivity in uremic patients maintained on hemodialysis. Arch. Allergy 47: 829.
12. 12. Dammin G J, Couch N P, Murray J E. 1957. Prolonged survival of skin homografts in uremic patients. Ann. N. Y. Acad. Sci. 64: 967.
13. 13. Smiddy F, Burwell R. 1961. Influence of uremia on the survival of skin homografts. Nature 190: 732.
14. 14. Stevens C. 1984. Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy. N. Engl. J. Med. 311: 496.
15. 15. Guidotti L G, Ishikawa T, Hobbs M V, Matzke B, Schreiber R, Chisari F V. 1996. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 4: 25.
16. 16. Guidotti L G, Chisari F V. 1996. To kill or to cure: options in host defence against viral infection. (Review) Curr. Opin. Immutol. 8: 478.
17. 17. Mosmann T R, Coffman R L. 1989. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. (Review) Annu. Rev. Immunol. 7: 145.
18. 18. Romagnani S. 1994. Lymphokine production by T cell in disease states. (Review) Annu. Rev. Immunol. 12: 227.
19. 19. Street N E, Mossman T R. 1991. Functional diversity of T lymphocytes due to secretion of different cytokine patterns. (Review) FASEb 5: 171.
20. + Th1 cells proinflammatory or anti-inflammatory? The ratio of IL-10 to IFN-γ or IL-2 determines their function. Int. Immunol. 7: 1287.
21. 21. Cohen S B, Katsikis P D, Chu C Q, Thomssen H, Webb L M, Maini R N, Londei M, Feldmann M, 1995. High level of interleukin-10 production by the activated T cell population within the rheumatoid synovial membrane. Arthritis. Rheum. 38: 946.
22. 22. Cohen S B, Clayton J, Londei M, Feldmann M. 1995. T cells and cytokines. In: Cytokines (2nd edition): A Practical Approach. (ed. F. Balkwel), Oxford University Press, 179.
23. 23. Zamauskaite A, Perez-Cruz I, Yaqoob M M, Madrigal J A, Cohen S B. 1999. Effect of renal dialysis therapy modality on T cell cytokine production. Nephrology, Dialysis, Transplantation 14: 49.
24. 24. Piraino B, Bernardini J, Holley J L, Perlmutter J A. 1993. A comparison of peritoneal dialysis related infections in short-and long -term peritoneal dialysis patients. Perit. Dial. Int. 13: 194.
25. 25. Hyde R. 1995. Autoimmune Diseases. Williams & Wilkins, Malvern.
26. 26. Druet P, Glotz D. 1992. Immune mechanisms of glomerular damage. In: Cameron S, Davison A, Grunfeld J, Kerr D, Rilz, E. Eds Oxford Textbook of Clinical Nephrology, New York: Oxford University Press, Vol. 1, 240.
27. 27. Descamps-Latscha B, Herbelin A, Nguyen A T, Zingraff J, Jungers P, Chatenoud L. 1994. Immune system dysregulation in uremia. (Review) Semin. Nephrol. 14: 253.
28. 28. Hakim R M. 1993. Clinical implications of haemodialysis membrane biocompatibility. Kidney Int. 44: 484.
29. 29. Pereira B J, Dinarello C A. 1994, Production of cytokines and cytokine inhibitory proteins in patients on dialysis. (Review) Nephrol. Dial. Transplant. 9 Suppl 2: 60.
30. 30. Fricke H, Hartmann J, Sitter T, Steldinger R, Ricber P, Schiffl H. 1996. Continuous ambulatory peritoneal dialysis impairs T lymphocyte selection in the peritoneum. Kidney Int. 49: 1386.
31. 31. Chatenoud L. 1992. Effects of chronic renal failure on the immune response. In: Cameron S, Davison A, Grunfeld J, Kerr D, Ritz E. Eds Oxford Textbook of Clinical Nephrology, New York: Oxford University Press, Vol. 2, 1312.